EP Patent

EP3923970B1 — Methods for increasing growth in pediatric subjects having cholestatic liver disease

Assigned to Mirum Pharmaceuticals Inc · Expires 2024-05-15 · 2y expired

What this patent protects

Patent listed against maralixibat-chloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP3923970B1
Jurisdiction
EP
Classification
—
Expires
2024-05-15
Drug substance claim
No
Drug product claim
No
Assignee
Mirum Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.